Navigation Links
Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals
Date:5/28/2008

Support networks and treatment choices can have a vital impact in helping

patients start and stay on therapy

DENVER, May 28 /PRNewswire/ -- Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying on therapy, according to a new North American survey of people with MS, results of which were released today at the Consortium of Multiple Sclerosis Centers annual meeting in Denver. However, the survey also found that people with the disease can face significant barriers that make it difficult for them to start or stay fully committed to an effective treatment regimen.(1)

The survey, which interviewed 220 people in the United States and Canada who have been diagnosed with MS in the past five years, uncovered a number of barriers patients face to starting and staying on medication, including the affordability of prescription medicine, injection-related issues and side effects, and the difficulty of maintaining a medication schedule.(1)

"Studies have shown that starting effective therapy soon after a diagnosis of MS and continuing that therapy on a consistent basis may significantly slow the progression of the disease.(2) This survey underscores the fact that despite their best intentions, many people with MS need help overcoming challenges that keep them from fully committing to treatment," said Amy Perrin Ross, APRN, MSN, CNRN, MSCN, president of the International Organization of MS Nurses. "The good news is there are several things that can be done to help give patients the best chance of starting and staying on therapy, including exploring financial assistance programs, forming lasting partnerships with an MS nurse and other supporters and choosing an effective MS medication that addresses a patient's personal hurdles. This can mean looking at attributes of a medication such as proven eff
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
2. Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD
3. Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD
4. Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks
5. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
6. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
7. Paramed Systems Achieves Significant Business Milestone in the Offshore Oil and Gas Evacuation Market
8. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
9. U.S. Patent Office Allows Another Significant VNUS Patent
10. Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms
11. Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...wswire/ -- Album Creative Studios, Inc., a full-se... offering big brand marketing for small businesses...d agency process and services, and tailored them t... says Matt Parker, Creative Director. Album Crea...oven brand-building techniques to build "Rockstar ...
(Date:11/21/2008)...rk together to stop abusive behavior, experts say ...Behavior that was once dismissed as "kids being ki...nting research shows the negative effects on both ...als, schools, parents and even kids themselves are...g behavior. , "Bullying shouldn,t be considere...
(Date:11/21/2008)...tate University College of Medicine research team ...ew layer of regulation in the cell division cycle,...e way cancer begins. , Wang, an assistant profes...ine, said the findings will lead to an improved ab...ign of new drugs that kill cancer cells by inhibit...
(Date:11/21/2008)...-USNewswire/ -- During a memorial service in the ... remembered Lieutenant Governor Catherine Baker Kn... public service, and a tireless advocate for the p...man elected lieutenant governor, Catherine was a n...ndell. "Her family and her faith were driving forc...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3
...veals that hardly 29 per cent of the asthmatic chi...Health officials have termed// it as a dangerous t...u. It was a dangerous trend, health officials hav...been warned that asthmatic children could die of f...
...sphincters could help stop persistent urine leakag...en// removed. Researchers from the Medical Colleg...device on a group of elderly men, in the age group...effective. Those, in whom the device was inserted,...
... are suffering from mental illness after serving i...t 18 months or longer for treatment// from the Nat...res released by British Ministry of Defence (MoD) ... been treated for mental health conditions after r...
...dustry representatives in Sydney has come out with...om their products//. The move follows similar ones...ndustry in Australia is also coming under pressure...h the issue, or else face regulatory requirements....
Other Medicine News:
(Date:11/19/2008).... 19 Amgen,(Nasdaq: A... a subsidiary of,Takeda Pharmaceutical Company Li...t in the Phase 3 MONET1 trial evaluating motesanib...boplatin for the first-line treatment of,advanced...rarily suspended,following a planned safety data ...
(Date:11/19/2008)...nt from Roche- , , MONTVALE, N.J., Nov. 19 ...orp. (Nasdaq: MEMY ) today announced that it has...l of R3487/MEM 3454, its lead alpha-7 nicotinic re... with schizophrenia (CIAS). The Company has rando...g a $5.0 million payment from its partner Roche. ...
(Date:11/18/2008)...s 2008 Faces of Influenza survey underscores that ...luenza; Mother and Gold Medalist Kristi Yamaguchi ...PRNewswire/ -- While 78 percent of mothers in the ...ntially life-threatening disease that can strike a...ill get vaccinated this season, according to a new...
(Date:11/12/2008)...ewswire-USNewswire/ -- A new study being,published... answer the,question, what causes Parkinson,s dise...edical research into,Parkinson,s disease is what c...he first place. Answering this question has been e...dentical types of brain cells that produce,dopamin...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology 15101 1Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology 15101 2Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance 15097 1Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance 15097 2ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans 1590 1ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans 1590 2ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans 1590 3ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans 1590 4Epilepsy marked by neural hub network 15092 1Epilepsy marked by neural hub network 15092 2
...erable Chronic,Thromboembolic Pulmonary Hypertensi...scular Resistance Met - Six-Minute-walk,Test Uncha...ological Disease Marker , , ALLSCHWIL, Switzerla...ced today the initial results from the double-blin...Bosentan Effects in,Inoperable Forms of Chronic Th...
...s the Genome From 242,Patients and Identifies New ...eukemia, Suggesting New Targets for Improved Thera... Investigators at,St. Jude Children,s Research Hos...ions that contribute to the formation of pediatric...on cancer in,children. The discovery not only sugg...
Other Medicine Technology:Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 2Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 3Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 4Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 5Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 6Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
TriActive is the result of DEKA's new technology based on,the combination of three different methods capable of restoring,a normal balance to your skin.,This treatment is designed to dramatical
The Salt A-Peel™ microdermabrasion combines, positive air pressure, pure salt, ultrasound and the application of rich anti oxidant products to deliver a remarkable 'The Salt A-Peel' anti ageing
...mabrasion systems offer many features that add val... money. Because our MegaPeel microdermabrasion sys...maintain, you spend your time treating patients/cl...ipment. MegaPeel microdermabrasion systems are ava...
... is a state-of-the-art hair reduction and skin rej...signed for use within a clinic or medspa environme...ngle portable device. Used effectively for the tre...tive acne, Chromolite™ uses proprietary Smar...
Medicine Products: